Gregory L. Weaver, Chief Financial Officer at Eloxx Pharmaceuticals, Inc. (ELOX), bought 4,500 shares at $8.56 ($39K) on 2018-03-23, disclosed to the SEC on 2018-03-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALT | BUY | 2025-03-14 | $52K | — | Filing → |
| ATOS | SELL | 2023-11-17 | $33K | — | Filing → |
| ATOS | BUY | 2023-06-20 | $49K | — | Filing → |